Session Information
2010 Midyear Clinical Meeting
Click here to go to the previous page
Clinical Considerations for Drug Dosing in Obesity
Track:
Education Sessions (CE)
Program Code: 267-L01
Date: Thursday, December 9, 2010
Time: 9:00 AM to 11:30 AM EST
Location:
Room 201A, Level 2
PRESENTER(S):
Jeffrey Barletta, Clinical Specialist, Critical Care, Midwestern University, College of Pharmacy
Elizabeth Farrington
PROGRAM CHAIR:
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
LEARNER OUTCOMES:
- Apply a process for determining the initial dosing regimen for an adult obese patient when limited dosing information is not available in the usual product information brochures.
- Apply a process for determining the initial dosing regimen in a pediatric obese patient when limited dosing information is not available in the usual product information brochures.
- Determine correct dosing of beta-lactam antimicrobials in obese patients.
- Determine correct dosing of heparin and low molecular weight heparins in obese patients.
- Discuss the limitations of using adjusted body weight calculations for drug dosing in obese patients.
This session is a part of:
Handout Online
